Mechanism of Alzheimer Type II Astrocyte Development in Hepatic Encephalopathy.

Journal: Neurochemistry international

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Departments of Pathology, University of Miami School of Medicine, Miami FL, USA. Departments of Obstetrics, Gynecology and Reproductive Sciences, University of Miami School of Medicine, Miami FL, USA; Departments of Biochemistry & Molecular Biology, University of Miami School of Medicine, Miami FL, USA. Molecular Analytics, Miami, FL, USA. General Medical Research, R&D Services, Department of Veterans Affairs, Miami FL, USA. General Medical Research, R&D Services, Department of Veterans Affairs, Miami FL, USA; Department of Pathophysiology, Faculty of Medicine, University of Szeged, Hungary. Larkin Community Hospital, Department of Internal Medicine and Infectious Disease, Miami, FL, USA. Laboratory of Anthropogenic, Biotechnology, and Health, Nutritional Physiopathologies, Neuroscience and Toxicology Team, Faculty of Sciences, Chouaib Doukkali University, Av Des facultés, , El Jadida. Morocco; The Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Health Sciences and Technology, Morocco. Department of Chemistry, School of Chemical and Biotechnology, SASTRA Deemed University, Tamil Nadu, India. Pathology and Laboratory Medicine, Department of Veterans Affairs, Miami FL, , USA. Departments of Obstetrics, Gynecology and Reproductive Sciences, University of Miami School of Medicine, Miami FL, USA. Endocrine, Polypeptide, and Cancer Institute, Department of Veterans Affairs, Miami FL, , USA. Medical Academy for Science and Technology, Homestead, FL, USA. Departments of Obstetrics, Gynecology and Reproductive Sciences, University of Miami School of Medicine, Miami FL, USA; General Medical Research, R&D Services, Department of Veterans Affairs, Miami FL, USA; Neuropathology Section, Veterans Affairs Medical Center, Miami FL, USA; R&D Services and South Florida VA Foundation for Research and Education Inc, Veterans Affairs Medical Center, Miami FL, USA. Electronic address: avrj_@yahoo.com.

Abstract summary 

Type C hepatic encephalopathy (Type C HE) is a major and complex neurological condition that occurs following chronic liver failure. The molecular basis of Type C HE remains elusive. Type C HE is characterized by mental confusion, cognitive and motor disturbances. The presence of Alzheimer type II astrocytes (AT2A) is the key histopathological finding observed in Type C HE. However, nothing is currently known regarding AT2A development and its involvement in cognitive, and motor deficits in Type C HE. We, therefore, examined in rats the mechanisms by which liver failure contributes to the progression of AT2A, and its role in the development of cognitive and motor deficits in thioacetamide (TAA) model of Type C HE. We and others earlier reported increased oxidative/nitrosative stress (ONS), JNK1/2, and cMyc activation in ammonia-treated astrocyte cultures, as well as in brains from chronic liver failure. We now found increased levels of astrocytic glia maturation factor (GMF, a factor strongly implicated in neuroinflammation), as well as various inflammatory factors (IL-1β, TNF-α, IL-6, MMP-3, COX2, CXCL1, and PGE2), and reduced levels of GFAP and increased levels of aggregated nuclear protein Lamin A/C in rat brain cortex post-chronic liver failure. We also found increased levels of GMF and inflammatory factors (MMP-3, COX2, CXCL1, and PGE2) in astrocytes post-ammonia treatment in vitro. Additionally, pharmacological inhibition of upstream signaling of GMF (ONS, JNK1/2, and cMyc) or GMF inhibitors W-7 and trifluoperazine significantly reduced the levels of inflammatory factors, the number of AT2A cells, as well as the cognitive and motor deficits in TAA-treated rats. Increased levels of GMF were also identified in human post-mortem brain sections. These findings strongly suggest that increased levels of astrocytic GMF due to elevated levels of ONS, JNK1/2, and cMyc and the subsequent inflammation contribute to the development of AT2A and the consequent cognitive, and motor deficits in chronic liver failure.

Authors & Co-authors:  Tong Xiao Y XY Norenberg Michael D MD Paidas Michael J MJ Shamaladevi Nagarajarao N Salgueiro Luis L Jaszberenyi Miklos M John Binu B Hussain Hussain H El Hiba Omar O Abdeljalil El Got EG Bilal El-Mansoury EM Natarajan Sampath S Romaguera Rita R Papayan Stanislav S Carden Arianna K AK Ramamoorthy Rajalakshmi R Elumalai Nila N Schally Andrew V AV Nithura Jayakumar J Patrizio Rebecca R Jayakumar Arumugam R AR

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  21
Identifiers
Doi : 10.1016/j.neuint.2024.105866
SSN : 1872-9754
Study Population
Male,Female
Mesh Terms
Other Terms
Ammonia;cognitive and motor deficits;glia maturation factor;hepatic encephalopathy;inflammatory factors
Study Design
Study Approach
Country of Study
Publication Country
England